Market Cap 87.43B
Revenue (ttm) 359.05B
Net Income (ttm) 3.30B
EPS (ttm) N/A
PE Ratio 20.95
Forward PE 18.62
Profit Margin 0.92%
Debt to Equity Ratio -6.64
Volume 961,100
Avg Vol 701,020
Day's Range N/A - N/A
Shares Out 125.11M
Stochastic %K 38%
Beta 0.50
Analysts Strong Sell
Price Target $789.47

Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business soluti...

Industry: Medical Distribution
Sector: Healthcare
Phone: 972 446 4800
Address:
6555 State Highway 161, Irving, United States
ChessGM
ChessGM Aug. 2 at 2:57 PM
$MCK "Heads up alert! Upcoming earnings on Wednesday, 8/6/2025 for $MCK Bullish (7.8) Financial Analysis: McKesson Corporation (NYSE: MCK) is experiencing a robust market presence, driven by strong financial performance and strategic initiatives. The company's Price-to-Earnings (P/E) ratio, a critical valuation metric, indicates that MCK is trading at a reasonable level compared to its historical averages and industry peers, suggesting potential upside for investors. Furthermore, McKesson has demonstrated impressive earnings per share (EPS) growth, bolstered by its strategic divestiture of the Medical-Surgical Solutions segment into ""NewCo,"" aimed at enhancing operational focus and shareholder value. Revenue forecasts for McKesson reflect a positive trajectory, with projections indicating continued growth driven by expansion in core business areas and strategic partnerships in the cell and gene therapy logistics market. This sector is expected to grow significantly, with McKesson positioned as a key player. Comparatively, McKesson's growth rate and financial metrics place it ahead of many of its peers in the healthcare distribution sector, reinforcing its status as a strong investment option. The recent increase in the quarterly dividend by 15% to $0.82 per share further underscores McKesson's commitment to returning capital to shareholders and reflects confidence in its cash flow generation capabilities. Upcoming Earnings Report: McKesson is set to release its fiscal first-quarter 2026 earnings on August 6, 2025. Analysts are forecasting single-digit earnings growth, reflecting a continuation of the company's steady financial performance. Historically, McKesson has a strong track record of meeting or exceeding earnings expectations, which bolsters confidence among investors and analysts alike. The market will closely watch for updates on the company's strategic initiatives, particularly in the areas of digital transformation and expansion in high-growth sectors. The earnings report is expected to have a significant impact on the stock, with potential for further appreciation if McKesson exceeds market expectations. Sector Performance: The healthcare distribution sector, which includes McKesson, has been experiencing a period of solid performance, driven by increasing demand for healthcare services and innovations in logistics and supply chain management. The sector's growth is supported by demographic trends, such as an aging population and increasing healthcare needs, which provide a stable backdrop for sustained expansion. Peers like Cardinal Health and Cencora are also benefiting from these trends, though McKesson's strategic initiatives and financial metrics position it as a leader in the sector. The sector's overall performance remains robust, with companies increasingly focusing on digital solutions and strategic partnerships to drive future growth. - Funds were net buyers of $MCK during the previous reporting quarter. - Funds with large holdings in $MCK include: - Holocene Advisors LP, MV: $394MM. New position. Fund Rank: 92% www.holoceneadvisors.com - Farallon Capital Management LLC, MV: $372MM. Fund Rank: 70% www.faralloncapital.com - Adage Capital P, MV: $147MM. Fund Rank: 86% www.adagecapital.com - Glenview Capital Management LLC, MV: $55MM. Fund Rank: 74% - Rhenman Asset Management, MV: $32MM. Fund Rank: 65% www.rhepa.se/en - Last 10 days performance: -2% - Last 30 days performance: -2% - Last 90 days performance: -2% Some of the latest news articles: - Title: Hims & Hers Stock to Report Q2 Earnings: What's in the Cards? Publication Date: 8/1/2025 4:18:00 PM, Source: yahoo URL: https://finance.yahoo.com/news/hims-hers-stock-report-q2-161800798.html?.tsrc=rss - Title: Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics Publication Date: 8/1/2025 1:15:03 PM, Source: yahoo URL: https://finance.yahoo.com/news/unlocking-q1-potential-mckesson-mck-131503595.html?.tsrc=rss - Title: Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention? Publication Date: 8/1/2025 12:00:34 PM, Source: yahoo URL: https://finance.yahoo.com/news/mckessons-nyse-mck-earnings-warrant-120034135.html?.tsrc=rss - Title: Why McKesson (MCK) Dipped More Than Broader Market Today Publication Date: 7/31/2025 9:50:04 PM, Source: yahoo URL: https://finance.yahoo.com/news/why-mckesson-mck-dipped-more-215004093.html?.tsrc=rss Follow us on stocktwits.com and Substack (chessgmstocks.substack.com). Not a financial advice. Not a trading signal."
0 · Reply
DividendPower
DividendPower Aug. 2 at 12:10 AM
Recent Dividend Increases - Updated 08/01/25 https://www.dividendpower.org/dividend-increases/ $AWR $CLX $MCK $KWR $HESM
0 · Reply
kinderspiel
kinderspiel Aug. 1 at 6:56 PM
$MCK Mckesson Price $ 697.38 (+0.6%) Trade Count: 542 Total $ 5.81 M (90-Day Avg : 2.38 M) Call $ 5.36 M Put $ 453.1 K
0 · Reply
Osubuckeye134
Osubuckeye134 Jul. 31 at 6:44 PM
$CAH, $MCK, $COR it has to be understood, how big of an impact a pharma price reduction has on the big 3 distributors. The main drivers for revenue are: distribution fees & cash discounts, these are calculated as a percentage of revenue. Therefore if a drug is $1,000, lets just say they would normally make say $50. If the gov't pushes $LLY and others to reduce price, and the distributors now pay $500 for the same drug, they will then make $25. Same number of packages shipped, same number of invoices due from customers, same number of customer service calls...just a lower base of revenue. It's devastating to the business model, one that assumes inflation, not massive deflation overnight.
0 · Reply
Atlas_Portfolio
Atlas_Portfolio Jul. 28 at 5:11 PM
$MCK For technical analysis of your favorite stocks and crypto, subscribe now! https://atlasportfolio.beehiiv.com/
0 · Reply
JarvisFlow
JarvisFlow Jul. 16 at 1:01 PM
Morgan Stanley has adjusted their stance on McKesson ( $MCK ), setting the rating to Overweight with a target price of 770 → 810.
0 · Reply
FilingTracker
FilingTracker Jul. 14 at 9:24 PM
$MCK CEO sold 41% of position: https://www.sec.gov/Archives/edgar/data/927653/000106299325012830/xslF345X05/form4.xml
0 · Reply
HotStockNews
HotStockNews Jul. 14 at 1:09 PM
NASDAQ: $SNYR Breaking NEWS🚨 SNYR (McKesson Corp NYSE: $MCK - $700+ stock major company) Sales expected to double this year ''Synergy CHC Corp. (NASDAQ: SNYR) Secures Retail Deals with McKesson Canada and Others as FOCUSfactor Expansion Surges Across North America'' https://finance.yahoo.com/news/synergy-chc-corp-nasdaq-snyr-120000648.html
0 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 1:00 PM
Evercore ISI Group updates rating for McKesson ( $MCK ) to Outperform, target set at 760 → 800.
0 · Reply
DougAfter60
DougAfter60 Jul. 8 at 3:13 PM
$MCK picked up a few shares
0 · Reply
Latest News on MCK
Our Top 10 High Growth Dividend Stocks - July 2025

Jul 19, 2025, 8:00 AM EDT - 14 days ago

Our Top 10 High Growth Dividend Stocks - July 2025

APH AVGO BBVA BK CARR EME FIX


Our Top 10 High Growth Dividend Stocks - June 2025

Jun 21, 2025, 8:00 AM EDT - 6 weeks ago

Our Top 10 High Growth Dividend Stocks - June 2025

APH AVGO CF CTAS CTVA FIX HWM


McKesson to Host Investor Day on September 23, 2025

Jun 11, 2025, 8:00 AM EDT - 7 weeks ago

McKesson to Host Investor Day on September 23, 2025


McKesson Corporation Completes Acquisition of Core Ventures

Jun 3, 2025, 8:00 AM EDT - 2 months ago

McKesson Corporation Completes Acquisition of Core Ventures


McKesson: Sustained Rally Backed By Strong Financials

May 18, 2025, 3:40 AM EDT - 2 months ago

McKesson: Sustained Rally Backed By Strong Financials


Our Top 10 High-Growth Dividend Stocks -- May 2025

May 17, 2025, 8:30 AM EDT - 2 months ago

Our Top 10 High-Growth Dividend Stocks -- May 2025

AMH APH AVGO BCS BK BRO CI


McKesson To Spin-Off Its Medical-Surgical Solutions Business

May 15, 2025, 2:05 PM EDT - 2 months ago

McKesson To Spin-Off Its Medical-Surgical Solutions Business


McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript

May 8, 2025, 8:08 PM EDT - 3 months ago

McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript


McKesson to Spin Off Medical-Surgical Company

May 8, 2025, 5:40 PM EDT - 3 months ago

McKesson to Spin Off Medical-Surgical Company


McKesson Corporation Declares Quarterly Dividend

May 1, 2025, 8:00 AM EDT - 3 months ago

McKesson Corporation Declares Quarterly Dividend


McKesson Shares Rise Nearly 1% After Key Signal

Apr 24, 2025, 4:41 AM EDT - 3 months ago

McKesson Shares Rise Nearly 1% After Key Signal


Registration Opens for Annual McKesson ideaShare Conference

Apr 8, 2025, 9:00 AM EDT - 4 months ago

Registration Opens for Annual McKesson ideaShare Conference


Sit Out The Crash With These 5 Dividend Stocks

Apr 7, 2025, 11:55 AM EDT - 4 months ago

Sit Out The Crash With These 5 Dividend Stocks

MO NUE PEP PG


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 4 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

COR CVS PM


McKesson Shares Up Over 2% After Key Signal

Apr 3, 2025, 6:59 AM EDT - 4 months ago

McKesson Shares Up Over 2% After Key Signal


McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025

Mar 25, 2025, 1:13 AM EDT - 4 months ago

McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025


McKesson Keeps Growing, Eyeing Bigger Future

Mar 5, 2025, 7:13 AM EST - 5 months ago

McKesson Keeps Growing, Eyeing Bigger Future


McKesson Corporation (MCK) Q3 2025 Earnings Call Transcript

Feb 5, 2025, 8:20 PM EST - 6 months ago

McKesson Corporation (MCK) Q3 2025 Earnings Call Transcript


McKesson misses third-quarter revenue estimates

Feb 5, 2025, 6:05 PM EST - 6 months ago

McKesson misses third-quarter revenue estimates


McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network

Nov 9, 2024, 1:50 AM EST - 9 months ago

McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network


ChessGM
ChessGM Aug. 2 at 2:57 PM
$MCK "Heads up alert! Upcoming earnings on Wednesday, 8/6/2025 for $MCK Bullish (7.8) Financial Analysis: McKesson Corporation (NYSE: MCK) is experiencing a robust market presence, driven by strong financial performance and strategic initiatives. The company's Price-to-Earnings (P/E) ratio, a critical valuation metric, indicates that MCK is trading at a reasonable level compared to its historical averages and industry peers, suggesting potential upside for investors. Furthermore, McKesson has demonstrated impressive earnings per share (EPS) growth, bolstered by its strategic divestiture of the Medical-Surgical Solutions segment into ""NewCo,"" aimed at enhancing operational focus and shareholder value. Revenue forecasts for McKesson reflect a positive trajectory, with projections indicating continued growth driven by expansion in core business areas and strategic partnerships in the cell and gene therapy logistics market. This sector is expected to grow significantly, with McKesson positioned as a key player. Comparatively, McKesson's growth rate and financial metrics place it ahead of many of its peers in the healthcare distribution sector, reinforcing its status as a strong investment option. The recent increase in the quarterly dividend by 15% to $0.82 per share further underscores McKesson's commitment to returning capital to shareholders and reflects confidence in its cash flow generation capabilities. Upcoming Earnings Report: McKesson is set to release its fiscal first-quarter 2026 earnings on August 6, 2025. Analysts are forecasting single-digit earnings growth, reflecting a continuation of the company's steady financial performance. Historically, McKesson has a strong track record of meeting or exceeding earnings expectations, which bolsters confidence among investors and analysts alike. The market will closely watch for updates on the company's strategic initiatives, particularly in the areas of digital transformation and expansion in high-growth sectors. The earnings report is expected to have a significant impact on the stock, with potential for further appreciation if McKesson exceeds market expectations. Sector Performance: The healthcare distribution sector, which includes McKesson, has been experiencing a period of solid performance, driven by increasing demand for healthcare services and innovations in logistics and supply chain management. The sector's growth is supported by demographic trends, such as an aging population and increasing healthcare needs, which provide a stable backdrop for sustained expansion. Peers like Cardinal Health and Cencora are also benefiting from these trends, though McKesson's strategic initiatives and financial metrics position it as a leader in the sector. The sector's overall performance remains robust, with companies increasingly focusing on digital solutions and strategic partnerships to drive future growth. - Funds were net buyers of $MCK during the previous reporting quarter. - Funds with large holdings in $MCK include: - Holocene Advisors LP, MV: $394MM. New position. Fund Rank: 92% www.holoceneadvisors.com - Farallon Capital Management LLC, MV: $372MM. Fund Rank: 70% www.faralloncapital.com - Adage Capital P, MV: $147MM. Fund Rank: 86% www.adagecapital.com - Glenview Capital Management LLC, MV: $55MM. Fund Rank: 74% - Rhenman Asset Management, MV: $32MM. Fund Rank: 65% www.rhepa.se/en - Last 10 days performance: -2% - Last 30 days performance: -2% - Last 90 days performance: -2% Some of the latest news articles: - Title: Hims & Hers Stock to Report Q2 Earnings: What's in the Cards? Publication Date: 8/1/2025 4:18:00 PM, Source: yahoo URL: https://finance.yahoo.com/news/hims-hers-stock-report-q2-161800798.html?.tsrc=rss - Title: Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics Publication Date: 8/1/2025 1:15:03 PM, Source: yahoo URL: https://finance.yahoo.com/news/unlocking-q1-potential-mckesson-mck-131503595.html?.tsrc=rss - Title: Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention? Publication Date: 8/1/2025 12:00:34 PM, Source: yahoo URL: https://finance.yahoo.com/news/mckessons-nyse-mck-earnings-warrant-120034135.html?.tsrc=rss - Title: Why McKesson (MCK) Dipped More Than Broader Market Today Publication Date: 7/31/2025 9:50:04 PM, Source: yahoo URL: https://finance.yahoo.com/news/why-mckesson-mck-dipped-more-215004093.html?.tsrc=rss Follow us on stocktwits.com and Substack (chessgmstocks.substack.com). Not a financial advice. Not a trading signal."
0 · Reply
DividendPower
DividendPower Aug. 2 at 12:10 AM
Recent Dividend Increases - Updated 08/01/25 https://www.dividendpower.org/dividend-increases/ $AWR $CLX $MCK $KWR $HESM
0 · Reply
kinderspiel
kinderspiel Aug. 1 at 6:56 PM
$MCK Mckesson Price $ 697.38 (+0.6%) Trade Count: 542 Total $ 5.81 M (90-Day Avg : 2.38 M) Call $ 5.36 M Put $ 453.1 K
0 · Reply
Osubuckeye134
Osubuckeye134 Jul. 31 at 6:44 PM
$CAH, $MCK, $COR it has to be understood, how big of an impact a pharma price reduction has on the big 3 distributors. The main drivers for revenue are: distribution fees & cash discounts, these are calculated as a percentage of revenue. Therefore if a drug is $1,000, lets just say they would normally make say $50. If the gov't pushes $LLY and others to reduce price, and the distributors now pay $500 for the same drug, they will then make $25. Same number of packages shipped, same number of invoices due from customers, same number of customer service calls...just a lower base of revenue. It's devastating to the business model, one that assumes inflation, not massive deflation overnight.
0 · Reply
Atlas_Portfolio
Atlas_Portfolio Jul. 28 at 5:11 PM
$MCK For technical analysis of your favorite stocks and crypto, subscribe now! https://atlasportfolio.beehiiv.com/
0 · Reply
JarvisFlow
JarvisFlow Jul. 16 at 1:01 PM
Morgan Stanley has adjusted their stance on McKesson ( $MCK ), setting the rating to Overweight with a target price of 770 → 810.
0 · Reply
FilingTracker
FilingTracker Jul. 14 at 9:24 PM
$MCK CEO sold 41% of position: https://www.sec.gov/Archives/edgar/data/927653/000106299325012830/xslF345X05/form4.xml
0 · Reply
HotStockNews
HotStockNews Jul. 14 at 1:09 PM
NASDAQ: $SNYR Breaking NEWS🚨 SNYR (McKesson Corp NYSE: $MCK - $700+ stock major company) Sales expected to double this year ''Synergy CHC Corp. (NASDAQ: SNYR) Secures Retail Deals with McKesson Canada and Others as FOCUSfactor Expansion Surges Across North America'' https://finance.yahoo.com/news/synergy-chc-corp-nasdaq-snyr-120000648.html
0 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 1:00 PM
Evercore ISI Group updates rating for McKesson ( $MCK ) to Outperform, target set at 760 → 800.
0 · Reply
DougAfter60
DougAfter60 Jul. 8 at 3:13 PM
$MCK picked up a few shares
0 · Reply
PanicSeller8
PanicSeller8 Jul. 7 at 7:30 PM
$MCK Among the most underrated stocks around.
0 · Reply
30DeltaSpy
30DeltaSpy Jul. 7 at 1:16 PM
$MCK bullish
0 · Reply
PanicSeller8
PanicSeller8 Jun. 27 at 4:12 PM
$MCK New all time high and should stay relatively resilient when market pulls back.
0 · Reply
Headinghigher
Headinghigher Jun. 23 at 4:12 PM
$MCK any talk about a stock split here?
1 · Reply
PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
PanicSeller8
PanicSeller8 Jun. 12 at 7:38 PM
$MCK New all time high. One of the easiest longs there is.
0 · Reply
MaverikIT
MaverikIT Jun. 12 at 4:35 PM
@IsabellaDC @TheLongVol @Wigglyick $MCK
0 · Reply
JarvisFlow
JarvisFlow Jun. 11 at 2:40 PM
Morgan Stanley has adjusted their stance on McKesson ( $MCK ), setting the rating to Overweight with a target price of 745 → 770.
0 · Reply
DonCorleone77
DonCorleone77 Jun. 11 at 11:00 AM
$MCK McKesson raises FY26 adjusted EPS view to $36.90-$37.70 from $36.75-$37.55 In a regulatory filing on June 9, McKesson disclosed that executives were scheduled to meet with various investors and analysts. "During these meetings, they will discuss McKesson's growth strategies, operational performance, business and market trends and financial outlook. Today, McKesson is providing the following updates to its Fiscal Year 2026 Financial Outlook. McKesson is increasing its full year Adjusted Earnings per Diluted Share guide from a range of $36.75 to $37.55, to a new range of $36.90 to $37.70. McKesson is reaffirming its full year effective tax rate guidance of 17% to 19%. McKesson anticipates the effective tax rate for the first half of the fiscal year to be 17% to 20%, with a higher rate in Q1 than Q2, and the second half effective tax rate to be 16% to 19%. McKesson is reaffirming all other guidance provided on its earnings call on May 8," the filing stated.
0 · Reply
topstockalerts
topstockalerts Jun. 9 at 12:58 PM
$MCK McKesson raised its full-year outlook for adjusted earnings. The Irving, Texas, healthcare company said Monday it is increasing its range for adjusted earnings per share in fiscal 2026 to be $36.75 to $37.55. That is above the previous range of $36.90 to $37.70. McKesson reaffirmed the rest of the guidance it shared on May 8.
0 · Reply
LiveSquawk
LiveSquawk Jun. 9 at 12:04 PM
$MCK | McKesson Sees FY Adj EPS $36.90 To $37.70, Saw $36.75 To $37.55
0 · Reply
EPSMomentumStocks
EPSMomentumStocks Jun. 4 at 12:09 PM
A 90-day forward-looking analysis for $MCK, highlighting projected price trends, potential volatility, and key technical and fundamental factors expected to influence the stock’s performance over the upcoming quarter. #stocks #trading #investing
0 · Reply